| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.01B | — | +17.8% |
| Cost of Revenue | $238.6M | — | +19.7% |
| R&D Expense | $380.8M | — | +14.8% |
| SG&A Expense | $103.5M | — | -2.0% |
| Operating Income | -$80.3M | — | -126.3% |
| Pre-tax Income | -$63.5M | — | -1632.6% |
| Income Tax | $10.1M | — | +180.1% |
| Net Income | -$73.6M | — | -924.8% |
| EPS (Basic) | -$0.12 | — | -1300.0% |
| EPS (Diluted) | -$0.12 | — | -1300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $378.1M | -61.0% | -69.8% |
| Accounts Receivable | $830.4M | -16.8% | +17.0% |
| Current Assets | $2.24B | -36.9% | -34.1% |
| Total Assets | $4.65B | -15.4% | -12.1% |
| Current Liabilities | $530.8M | +14.0% | +31.2% |
| Total Liabilities | $1.79B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $328.0M | — | -9.8% |
| Capital Expenditures | $16.3M | — | +124.2% |
| Investing Cash Flow | $112.9M | — | +844.7% |
| Financing Cash Flow | -$1.03B | — | -295.9% |
| Free Cash Flow | $311.7M | — | -12.6% |
| +202.0% |
| Stockholders' Equity | $2.85B | -39.9% | -39.2% |